Geode Capital Management, LLC Sqz Biotechnologies CO Transaction History

Geode Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.67 - $2.85 $233 - $991	-348 Reduced 0.26%	135,360 $100,000
Q3 2022 Nov 14, 2022	BUY	$2.16 - $3.48 $30,473 - $49,095	14,108 Added 11.6%	135,708 $309,000
Q2 2022 Aug 12, 2022	SELL	$2.77 - $5.0 $528,042 - $953,145	-190,629 Reduced 61.05%	121,600 $386,000
Q1 2022 May 13, 2022	BUY	$4.01 - $10.42 $35,003 - $90,956	8,729 Added 2.88%	312,229 $1.5 Million
Q4 2021 Feb 11, 2022	BUY	$8.93 - $14.85 $396,947 - $660,097	44,451 Added 17.16%	303,500 $2.71 Million
Q3 2021 Nov 12, 2021	BUY	$11.46 - $15.77 $159,763 - $219,849	13,941 Added 5.69%	259,049 $3.74 Million
Q2 2021 Aug 13, 2021	BUY	$11.32 - $14.45 $1.76 Million - $2.25 Million	155,902 Added 174.77%	245,108 $3.54 Million
Q1 2021 May 12, 2021	BUY	$12.07 - $29.9 $175,280 - $434,207	14,522 Added 19.44%	89,206 $1.22 Million
Q4 2020 Feb 12, 2021	BUY	$13.25 - $34.58 $989,563 - $2.58 Million	74,684 New	74,684 $2.16 Million

1.47M

Ticker SQZ
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,248,600
Market Cap $1.46M
Description
SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination ...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.